Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
- PMID: 23181722
- PMCID: PMC3533813
- DOI: 10.1186/1756-9966-31-98
Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
Abstract
Cdx2 is a homeobox domain-containing transcription factor that is important in the development and differentiation of the intestinal cells, and served as a potential biomarker of tumor progression in early intestinal-type gastric cancer. However, its prognostic value and significance in gastric cancer remain controversial. A meta-analysis based on published studies was performed to obtain an accurate evaluation of the association between the presence of Cdx2-positive in clinical samples and clinical outcome. A total of 13 eligible retrospective cohort studies with 1513 patients were included. Cdx2-positive cases were significantly associated with higher male-to-female ratio (RR=1.27, 95% CI: 1.17-1.38, P<0.00001 fixed-effect), lower (I+II) clinical stage (RR=1.63, 95% CI: 1.42-1.87, P<0.00001 fixed-effect), better histologic differentiation (RR=1.54, 95% CI: 1.34-1.76, P<0.00001 fixed-effect), and lower rate of vascular invasion (RR=1.23, 95% CI: 1.08-1.41, P=0.002 fixed-effect) and lymph node metastasis (RR=1.52, 95% CI: 1.33-1.73, P<0.00001 fixed-effect), as well as higher 5-year survival rate (HR=2.22, 95% CI: 1.78-2.75, P<0.00001 fixed-effect). However, the presence of Cdx2 was not associated with tumor size. In summary, Cdx2 is a prognostic factor in gastric cancer, which acts as a marker of good outcome in patients with gastric cancer. Further clinical studies are needed to confirm the role of Cdx2 in clinical practice.
Figures




Similar articles
-
Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.Clin Cancer Res. 2005 Sep 1;11(17):6162-70. doi: 10.1158/1078-0432.CCR-05-0278. Clin Cancer Res. 2005. PMID: 16144916
-
Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.BMC Cancer. 2014 Oct 9;14:753. doi: 10.1186/1471-2407-14-753. BMC Cancer. 2014. PMID: 25300947 Free PMC article.
-
A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.Clin Oncol (R Coll Radiol). 2008 May;20(4):275-83. doi: 10.1016/j.clon.2008.01.013. Epub 2008 Mar 19. Clin Oncol (R Coll Radiol). 2008. PMID: 18353622
-
MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis.Dis Markers. 2016;2016:9421571. doi: 10.1155/2016/9421571. Epub 2016 Apr 17. Dis Markers. 2016. PMID: 27190429 Free PMC article. Review.
-
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.World J Surg Oncol. 2017 Mar 21;15(1):68. doi: 10.1186/s12957-017-1132-5. World J Surg Oncol. 2017. PMID: 28327158 Free PMC article. Review.
Cited by
-
Endobronchial Metastasis with Extension to the Left Atrium from Adenocarcinoma of Gastric 3 Years after Total Gastrectomy.Sultan Qaboos Univ Med J. 2025 May 2;25(1):150-153. doi: 10.18295/squmj.10.2024.066. Sultan Qaboos Univ Med J. 2025. PMID: 40641712 Free PMC article.
-
Association between interleukin-4 -590C > T polymorphism and non-Hodgkin's lymphoma risk.Tumour Biol. 2014 Apr;35(4):3041-5. doi: 10.1007/s13277-013-1394-7. Epub 2013 Nov 23. Tumour Biol. 2014. PMID: 24272083
-
New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.World J Gastroenterol. 2014 Apr 14;20(14):3960-6. doi: 10.3748/wjg.v20.i14.3960. World J Gastroenterol. 2014. PMID: 24744585 Free PMC article. Review.
-
Significance of glutathione peroxidase 1 and caudal-related homeodomain transcription factor in human gastric adenocarcinoma.Gastroenterol Res Pract. 2013;2013:380193. doi: 10.1155/2013/380193. Epub 2013 Oct 21. Gastroenterol Res Pract. 2013. PMID: 24228025 Free PMC article.
-
The role of CDX2 in renal tubular lesions during diabetic kidney disease.Aging (Albany NY). 2021 Feb 17;13(5):6782-6803. doi: 10.18632/aging.202537. Epub 2021 Feb 17. Aging (Albany NY). 2021. PMID: 33621200 Free PMC article.
References
-
- Xie Y, Li L, Wang X, Qin Y, Qian Q. Overexpression of Cdx2 inhibits progression of gastric cancer in vitro. Int J Oncol. 2010;36:509–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials